ORTIN GLOBAL LIMITED (ORTINGLOBE) fundamentals
ORTIN GLOBAL LIMITED is a listed company in Pharmaceuticals & Biotechnology, part of the Healthcare sector, listed on the NSE as ORTINGLOBE (ISIN INE749B01020). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What ORTIN GLOBAL LIMITED does
Ortin Global Limited is an India-based company, which is engaged in the manufacturing and trading of pharmaceuticals, drugs and intermediates, to manufacture, sell or export all types of medicines, including ayurvedic, homeopathic, Unani, biochemical, nature cure and others. The Company is also engaged in the real estate business.
Valuation and market data
| Last close | ₹17.11 |
|---|---|
| Market capitalisation | ₹14 crore |
| Enterprise value | ₹14 crore |
| P/E (TTM) | 0.00 |
| Price to book | 7.06 |
| Price to sales (TTM) | 39.95 |
| Book value per share | ₹2.42 |
| Dividend yield | 0.00% |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Listed since | Tue Mar 30 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹0 crore | ₹-1 crore | ₹-1 crore | 0.00 |
| Mar 2025 | ₹0 crore | ₹-1 crore | ₹-1 crore | -1.04 |
| Mar 2024 | ₹2 crore | ₹-7 crore | ₹-8 crore | -9.89 |
| Mar 2023 | ₹6 crore | ₹-0 crore | ₹-0 crore | -0.12 |
| Mar 2022 | ₹8 crore | ₹-1 crore | ₹-0 crore | -0.49 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 1.2% |
|---|---|
| Foreign institutions (FII) | 1.8% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.0% |
| Retail and others | 97.0% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.